Vital Signs Monitoring Devices Market - Global Outlook & Forecast 2023-2028

370 pages

159 tables

158 charts

5 region

19 countries

62 company

5 segments

Purchase Options

$4200.00
$4999.00
$5999.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE GLOBAL VITAL SIGNS MONITORING DEVICES MARKET IS EXPECTED TO REACH USD 33.36 BILLION BY 2028 FROM USD 20.60 BILLION IN 2022, GROWING AT A CAGR OF 8.36% DURING THE FORECAST PERIOD

The Vital Signs Monitoring Devices Market Size, Share, & Trends Analysis Report By

  • Product Type: Standalone Vital Sign Monitors (Heart Rate/ Cardiac Monitors, Pulse Oximeter, Blood Pressure Monitors, and Body Temperature Monitors) and Integrated Vital Sign Monitors
  • Patient Group: Geriatric, Pediatric, and Adults
  • Application: Chronic Care and Acute Care
  • End-users: Hospitals, Outpatient Care Settings, Homecare Settings & Individuals, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

VITAL SIGNS MONITORING DEVICES MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2028)USD 33.36 Billion
Market Size (2022)USD 20.60 Billion
CAGR (2022-2028)8.36%
Base Year2022
Forecast Year2023-2028
Market SegmentsProduct Type, Patient Group, Application, End-users, and Geography
Geographic AnalysisNorth America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORSA&D Company, Contec Medical Systems, GE Healthcare, Baxter, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems
Interested in this Report?

Download a Sample!

MARKET OUTLOOK

The global vital signs monitoring devices market was valued at USD 20.60 billion in 2022 and is expected to reach USD 33.36 billion by 2028, growing at a CAGR of 8.36%. In recent years, vital sign monitoring has expanded and extended beyond the limits of medical practices and most areas of everyday life. Previously, vital sign monitoring occurred in clinics, hospitals, and other healthcare systems under the appropriate medical supervision. But, in recent years, technological advances such as microelectronics have resulted in cost reductions in vital monitoring systems. These technologies are highly accessible and common in telemedicine, fitness, sports, wellness, and the workplace. Despite those expansions and given the health-associated nature of these applications, quality standards remain high. The growing requirement for continuous healthcare monitoring and the shortage of trained medical professionals offers a significant opportunity for advancement & innovations in the vital signs monitoring devices market. The microelectronic technologies & sensor domains have a vibrant innovation ecosystem focusing on multi-parametric sensing, improving sensitivity, & wireless sensing.

Vital sign monitoring involves measuring physiological parameters that can indicate health. Heart rate is one of the most common vital signs detected through the electrocardiogram principle. The recent advances in vital sign monitoring devices with Deep Learning (DL) and Machine Learning (ML) have strengthened the power of imaging techniques to help remotely perform many tasks which were previously required the physical presence of medical professionals. Also, the upcoming wearable vital sign monitoring devices positively influence the vital signs monitoring devices market growth.

MARKET TRENDS & OPPORTUNITIES

Technology Development in Vital Sign Monitoring Devices
With the advances in technologies in the vital signs monitoring devices market, advanced vital sign devices become more common in various healthcare filed and across daily lives. Whether it is used for prevention or management, such health-associated solutions call for robust and reliable technology. Internet of Things (IoT) is a major factor that penetrated 50% of healthcare in developed and rapidly developing countries, from patient care management to post-care. Recently, the advancement in vital sign monitoring devices, such as the addition of sensors, software integrations, digital screens, and mobile-based applications, resulted in rapid development.

Growing Shift Towards Remote Patient Monitoring (RPM)
RPM has enabled medical professionals to observe patients virtually along with vital clinical information and make decisions to improve care outcomes. In these procedures, vital sign monitoring devices accurately deliver clinical data to medical professionals. The increasing demand for remote patient monitoring is accelerating the growth of the vital signs monitoring devices market. Further, remote patient monitoring helps improve quality of life by being cost-effective and reducing the chance of hospitalization. In addition, the older population's preferences for home care settings are accelerating the demand for vital sign monitoring devices.

Enhance Adoption with Patient-centric Digital Systems with Wearable Devices & Telemedicine
In healthcare settings, increasing demand for telemedicine/telehealth is expected to drive remote monitoring. In contrast, accurate monitoring and diagnosis system will be most important to collect vital signs and other data points. Where the increasing shifts towards telemedicine platforms to deliver and receive care, vital sign monitoring devices are playing a vital role. As in healthcare management, multi-sensor and wearable technologies emerge, digital devices integration of electronic health records (EHRs) expects to optimize day-to-day operations and offers data for strategic decision making.

Increasing Burden of Chronic Disorders
Globally, healthcare settings are witnessing for increasing burden of chronic disorders. Chronic conditions pose a mental and financial burden. However, the vital signs monitoring devices market has witnessed huge growth and development. The year-on-year increasing patient population with minor to severe chronic conditions drives the significant demand for vital sign monitoring devices because it not only helps to reduce the burden but also offers early indications that reduce the risk of mortality, morbidity, and disability of individuals.

Available Integrated Vital Sign Monitoring Devices Offer More Benefits
In healthcare, vital sign monitoring systems are rapidly becoming more popular and core. It shifted the traditional paradigm and manual clinical data recording to computer-based electronic records and handheld devices as innovative and versatile healthcare monitoring systems. Still, there are a lot of challenges in patient monitoring. Based on that, integrating vital sign monitoring devices offers a lucrative advantage in driving the market growth. Furthermore, the term multiparameter monitors become more favorable over the last decades, which boosts the vital signs monitoring devices market growth. In healthcare settings and other external and internal health delivery systems, a multiparameter monitor is a major medical device for monitoring patients' vital signs. It is mostly used in intensive care units, emergency rooms, and hospitalizations.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT
The global vital signs monitoring devices market by product is segmented into standalone and integrated vital sign monitoring devices. The standalone vital sign monitoring devices include the heart rate/cardiac monitor, pulse oximeter, blood pressure monitor, and body temperature monitor. Standalone vital sign monitors are easy to transfer from one location to another. They are typically lightweight and compact, making it easy to keep looks on a given patient’s vital signs wherever they are. In 2022, the standalone vital sign monitors segment accounted for a higher industry share. A standalone system is envisioned that monitors all patients' vital signs and automatically alerts the required emergency response services upon recognizing a crisis condition.

INSIGHTS BY PATIENT GROUP
The global vital signs monitoring devices market by the patient group is segmented into geriatric, pediatric, and adult patient groups. With the growing burden of chronic diseases among geriatric populations, the demand for vital sign monitors is generally high. The geriatric segment dominated the market by over 53% share in 2022. The high hospitalization visits and the huge preference for outpatient and homecare settings are accelerating the demand for vital sign monitoring devices from the aging patient population.

INSIGHTS BY APPLICATION
The chronic care application segment dominated the global vital signs monitoring devices market. Chronic conditions are long-term impacting conditions with persistent effects. Their economic and social consequences can impact on people's quality of life. These conditions are becoming increasingly common and one of the priority areas of healthcare settings. Chronic diseases affect over 60% of the world's population and consume over 85% of healthcare expenditures. It indicates that huge opportunities are available for vendors with the increasing chronic disease burden worldwide.

INSIGHTS BY END-USER
The global vital signs monitoring devices market by end-user is segmented into hospitals, homecare settings & individuals, ambulatory care settings, and others. Hospitals are major healthcare settings worldwide, contributing to the huge demand for vital sign monitors. Hospitals are the primary source of care for every patient group. Millions of hospital visits and admissions are fuelling the demand for vital sign monitors. Also, developing vital sign monitoring devices with the integrated model approach accelerates the market growth.

GEOGRAPHY ANALYSIS

The North American region dominated the vital signs monitoring devices market share, accounting for over 35% in 2022. The early adoption of medical technologies across the U.S. drives vital sign monitoring devices' huge acceptance and application rate. The awareness about using vital sign monitors among individuals and the huge transformation of healthcare settings with digitalization and advanced technologies are accelerating the demand for standalone vital sign monitors across the US. In addition, the well-known approach for remote patient monitoring boosts the use of wearable vital sign monitors.

In Europe, the shift towards connected health technologies among patients and healthcare settings offers lucrative vital signs monitoring devices market growth opportunities. Currently, digital health technologies hold the potential to bring about huge improvements in the health systems of Europe in terms of care provision and administration. Furthermore, the challenges posed by COVID-19 have created different requirements and a new willingness to adopt connected health technologies.

In APAC, several countries have been focusing on implementing telemedicine platforms recently, shifting people's preference from hospital-based medical services to day-to-day healthcare services at home. The Asia-Pacific Economic Corporation (APEC) is actively helping and promoting the use of telemedicine platforms in the region, which is expected to drive around 50% growth in telemedicine in the upcoming ten years. Japan and Korea have a huge medical information foundation and gradually support telemedicine platforms. Thereby accelerating the demand for remote patient monitoring and supporting the vital signs monitoring devices market.

VENDOR LANDSCAPE

The vital signs monitoring devices market is highly competitive and has several major players. The fragmented market has various global, local, and regional manufacturers. Owing to continuous technological advancements and product innovations, mid-sized and emerging vendors are increasing their market presence by introducing new products at competitive prices. Also, the market potential drives several players to expand their industry share through acquisitions. Many vendors are adopting strategies to increase their presence in major markets. Larger players also tend to acquire other companies as a whole or specific product portfolio.

A&D Company, Hillrom, Masimo, Medtronic, Koninklijke Philips, GE Healthcare, Contec Medical Systems, NIHON KOHDEN, and Smiths Medical are some of the major vendors in the global vital signs monitoring devices market offering a wide range of both standalone and integrated vital signs monitors worldwide. All these companies have a significant presence in major geographical regions such as North America, APAC, and Europe. However, many local vendors provide products with similar specifications at lower prices, which has resulted in a price war among vendors. The major vendors continuously compete for the leading position in the market, with occasional competition coming from other local vendors.

Frequently Asked Questions

How big is the global vital signs monitoring devices market?

The global vital signs monitoring devices market size was valued at USD 20.60 billion in 2022 and is expected to reach USD 33.36 billion by 2028.

What is the growth rate of the vital signs monitoring devices market?

The global vital signs monitoring devices market is growing at a CAGR of 8.36% from 2022-2028.

What are the rising trends in the vital signs monitoring devices industry?

The rising trends in the vital signs monitoring devices industry are technology development in vital sign monitoring devices, a growing shift towards remote patient monitoring technology, and enhanced adoption of patient-centric digital systems with wearable devices & telemedicine.

Which region holds the most significant global vital signs monitoring devices market share?

North America dominated the global vital signs monitoring devices market share in 2022, accounting for over 35%.

Who are the key players in the global vital signs monitoring devices market?

A&D Company, Contec Medical Systems, GE Healthcare, Baxter, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems are the key players in the vital global vital signs monitoring devices market.

The global vital signs monitoring devices market is expected to grow at a CAGR of approximately 8.36% from 2022 to 2028.

The following factors are likely to contribute to the growth of the vital signs monitoring devices market during the forecast period:

  • Increasing Burden of Chronic Disorders
  • Available Integrated Vital Sign Monitoring Devices Offer More Benefits
  • Paradigm Shift Towards Outpatient Care
  • Increasing Patient Population and Shortage of Healthcare Workers

Base Year: 2022

Forecast Year: 2023-2028

The report considers the present scenario of the global vital signs monitoring devices market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  • A&D Company
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Contec Medical Systems
  • GE Healthcare
  • Baxter
  • ICU Medical
  • Koninklijke Philips
  • Masimo
  • Medtronic
  • NIHON KOHDEN
  • Nonin
  • OMRON
  • OSI Systems

Other Prominent Vendors

  • 100-plus
    • Product Offerings
    • Business Overview
  • Arjo
  • American Diagnostic
  • Advanced Instrumentations
  • Biofourmis
  • Bittium
  • BioIntelliSense
  • Cardinal Health
  • Compass Health Brands
  • Drägerwerk AG & Co.
  • Essence
  • EDAN Instruments
  • FUKUDA DENSHI
  • Halma
  • Infinium Medical
  • Mennen Medical
  • Microlife
  • NURECA
  • Oxitone
  • Qardio
  • Rossmax International
  • Solaris Medical Technology
  • Sunset Healthcare Solutions
  • Turtle Shell Technologies Pvt. Ltd.
  • Viatom Technology
  • VitalConnect
  • VivaLNK
  • VYAIRE MEDICAL
  • Cosinuss
  • Better Life Medical Technology
  • TaiDoc
  • aXcent medical
  • General Meditech
  • Clarity Medical
  • Hicks Thermometers India
  • medical Econet
  • Meditech
  • Shenzhen Creative Industry
  • Progetti
  • GETEMED Medical and Information Technology
  • Shenzhen Unicare Electronic
  • Opto Circuits (India)
  • Beijing Choice Electronic Technology
  • Shenzhen Mindray Bio-Medical Electronics
  • Remote Diagnostic Technologies
  • Samtronic
  • Charmcare
  • AVI Healthcare
  • Recorders & Medicare Systems
  • Acare Technology

Segmentation by Product Type

  • Standalone Vital Sign Monitors
    • Heart Rate/ Cardiac Monitors
    • Pulse Oximeter
    • Blood Pressure Monitors
    • Body Temprature Monitors
  • Integrated Vital Sign Monitors

Segmentation By Patient Group

  • Geriatric
  • Pediatric
  • Adults

Segmentation by Application

  • Chronic Care
  • Acute Care

Segmentation By End-users

  • Hospitals
  • Outpatient Care Settings
  • Homecare Settings & Individuals
  • Others

Segmentation By Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • UAE

EXHIBIT 1 SEGMENTATION OF GLOBAL VITAL SIGNS MONITORING DEVICES MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 VITAL SIGN MONITORING METHODS

EXHIBIT 4 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET SEGMENTATION

EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN VITAL SIGNS MONITORING DEVICES

EXHIBIT 6 IMPACT OF SHIFT TOWARD REMOTE PATIENT MONITORING TECHNOLOGIES

EXHIBIT 7 STATISTICS ABOUT REMOTE PATIENT MONITORING

EXHIBIT 8 PARAMETERS FOR EFFICACY OF REMOTE PATIENT MONITORING AMONG US PATIENTS (%)

EXHIBIT 9 VOLUME OF HEALTH INSURANCE CLAIMS FOR GENERAL RPM & CONTINUOUS GLUCOSE MONITORING (PRE-PANDEMIC & PANDEMIC PERIOD)

EXHIBIT 10 IMPACT OF HIGH ADOPTION OF PATIENT-CENTRIC DIGITAL SYSTEMS & TELEMEDICINE

EXHIBIT 11 IMPACT OF RISE IN BURDEN OF CHRONIC DISORDERS

EXHIBIT 12 GLOBAL BURDEN OF CHRONIC DISORDERS 2020

EXHIBIT 13 GLOBAL DIABETES PREVALENCE BY GEOGRAPHIES 2020 (MILLION)

EXHIBIT 14 IMPACT OF AVAILABILITY OF INTEGRATED VITAL SIGNS MONITORING DEVICES

EXHIBIT 15 IMPACT OF PARADIGM SHIFT TOWARD OUTPATIENT CARE

EXHIBIT 16 MAJOR ADVANTAGES OF AMBULATORY CARE SETTINGS

EXHIBIT 17 IMPACT OF EXPANSION OF PATIENT POPULATIONS & SHORTAGE OF HEALTHCARE WORKERS

EXHIBIT 18 IMPACT OF VITAL SIGN MONITORING DEVICES ON AGING POPULATION CARE AND SHORTAGE OF HEALTHCARE WORKERS

EXHIBIT 19 IMPACT OF CHALLENGES ASSOCIATED WITH REMOTELY MONITORING PATIENTS THROUGH VITAL SIGN MONITORS

EXHIBIT 20 IMPACT OF FALSE ALARMS RELATED TO VITAL SIGN MONITORING DEVICES

EXHIBIT 21 IMPACT OF CYBERSECURITY & RELATED LIMITATIONS OF VITAL SIGNS MONITORING DEVICES

EXHIBIT 22 IMPACT OF PERCEPTIONS OF INADEQUATE ACCURACY & RELIABILITY OF WIRELESS VITAL SIGNS MONITORING DEVICES

EXHIBIT 23 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: MARKET SHARE 2022 & 2028

EXHIBIT 24 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET: MARKET SHARE 2022 & 2028

EXHIBIT 25 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: MARKET SHARE 2022 & 2028

EXHIBIT 26 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: MARKET SHARE 2022 & 2028

EXHIBIT 27 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USERS: MARKET SHARE 2022 & 2028

EXHIBIT 28 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2022 & 2028

EXHIBIT 29 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 30 FIVE FORCES ANALYSIS 2022

EXHIBIT 31 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 32 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028

EXHIBIT 33 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: SEGMENTAL OVERVIEW

EXHIBIT 34 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 35 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 36 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 37 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 38 APPLICATIONS OF HEART RATE MONITORS

EXHIBIT 39 GROWTH FACTORS & CHALLENGES FOR WEARABLE HEART RATE MONITORS

EXHIBIT 40 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY HEART RATE/ CARDIAC MONITORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY HEART RATE/ CARDIAC MONITORS 2022–2028 ($ BILLION)

EXHIBIT 42 APPLICATIONS OF PULSE OXIMETERS

EXHIBIT 43 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY PULSE OXIMETERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 44 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY PULSE OXIMETERS 2022–2028 ($ BILLION)

EXHIBIT 45 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BLOOD PRESSURE MONITORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 46 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BLOOD PRESSURE MONITORS 2022–2028 ($ BILLION)

EXHIBIT 47 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BODY TEMPERATURE MONITORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 48 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BODY TEMPERATURE MONITORS 2022–2028 ($ BILLION)

EXHIBIT 49 INTEGRATION OF VITAL SIGN MONITORING DEVICES AND THEIR IMPACT

EXHIBIT 50 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 51 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 52 INCREMENTAL GROWTH BY PATIENT GROUP 2022 & 2028

EXHIBIT 53 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028

EXHIBIT 54 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: SEGMENTAL OVERVIEW

EXHIBIT 55 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: INCREMENTAL GROWTH

EXHIBIT 56 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: ABSOLUTE GROWTH

EXHIBIT 57 GLOBAL PREVALENCE OF CHRONIC CONDITIONS AMONG GERIATRICS THAT REQUIRE VITAL SIGN MONITORING DEVICES

EXHIBIT 58 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 59 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP 2022–2028 ($ BILLION)

EXHIBIT 60 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 61 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP 2022–2028 ($ BILLION)

EXHIBIT 62 GLOBAL PREVALENCE OF CHRONIC DISEASES AMONG ADULTS 2021

EXHIBIT 63 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 64 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP 2022–2028 ($ BILLION)

EXHIBIT 65 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028

EXHIBIT 66 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028

EXHIBIT 67 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: SEGMENTAL OVERVIEW

EXHIBIT 68 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: INCREMENTAL GROWTH

EXHIBIT 69 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: ABSOLUTE GROWTH

EXHIBIT 70 BENEFITS OF REMOTE MONITORING & VITAL SIGN MONITORS FOR CHRONIC CARE MANAGEMENT

EXHIBIT 71 GLOBAL BURDEN OF MAJOR CHRONIC CONDITIONS

EXHIBIT 72 DISTRIBUTION OF REMOTE PATIENT MONITORING ACCORDING TO CHRONIC CONDITIONS 2021

EXHIBIT 73 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 74 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE 2022–2028 ($ BILLION)

EXHIBIT 75 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 76 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE 2022–2028 ($ BILLION)

EXHIBIT 77 INCREMENTAL GROWTH BY END USER 2022 & 2028

EXHIBIT 78 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028

EXHIBIT 79 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER: SEGMENTAL OVERVIEW

EXHIBIT 80 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USERS: INCREMENTAL GROWTH

EXHIBIT 81 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USERS: ABSOLUTE GROWTH

EXHIBIT 82 MAJOR VITAL SIGN MONITORING DEVICES REQUIRED IN HOSPITAL SETTINGS

EXHIBIT 83 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 84 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS 2022–2028 ($ BILLION)

EXHIBIT 85 ROLE OF VITAL SIGN MONITORS IN AMBULATORY CARE SETTINGS

EXHIBIT 86 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 87 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS 2022–2028 ($ BILLION)

EXHIBIT 88 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 89 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS 2022–2028 ($ BILLION)

EXHIBIT 90 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 91 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS 2022–2028 ($ BILLION)

EXHIBIT 92 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028

EXHIBIT 93 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028

EXHIBIT 94 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: GEOGRAPHIC OVERVIEW

EXHIBIT 95 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 96 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 97 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 98 NORTH AMERICA MAJOR CHRONIC CONDITIONS & ASSOCIATED PATIENT POPULATION

EXHIBIT 99 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES

EXHIBIT 100 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 101 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028

EXHIBIT 102 GROWTH OF RPM INTEGRATION IN US

EXHIBIT 103 US VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 104 CANADA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 105 EUROPE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 106 EUROPE VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES

EXHIBIT 107 EUROPE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 108 INCREMENTAL GROWTH IN EUROPE 2022 & 2028

EXHIBIT 109 PREFERENCE FOR CONTINUOUS GLUCOSE MONITORING DEVICES IN GERMANY 2022 (%)

EXHIBIT 110 GERMANY VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 111 FRANCE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 112 PREVALENCE OF MAJOR CHRONIC DISEASES IN UK 2023

EXHIBIT 113 UK VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 114 ITALY VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 115 SPAIN VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 116 APAC VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES

EXHIBIT 117 APAC VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 118 APAC VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 119 INCREMENTAL GROWTH IN APAC 2022 & 2028

EXHIBIT 120 ABSOLUTE BURDEN OF HYPERTENSION AMONG ADULTS IN 18–69 AGE GROUP IN CHINA 2004–2018

EXHIBIT 121 CHINA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 122 TOP 10 DISEASES WITH HIGHEST MORTALITY RATE IN JAPAN 2020

EXHIBIT 123 JAPAN VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 124 CHRONIC & ACUTE DISEASES BURDEN IN INDIA

EXHIBIT 125 INDIA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 126 PREVALENCE OF CHRONIC DISEASES IN SOUTH KOREA IN 2022

EXHIBIT 127 SOUTH KOREA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 128 CHRONIC DISEASES PREVALENCE IN AUSTRALIA 2020

EXHIBIT 129 AUSTRALIA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 130 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 131 MAJOR CHRONIC DISEASES BURDEN IN LATIN AMERICA 2022

EXHIBIT 132 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES

EXHIBIT 133 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 134 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028

EXHIBIT 135 BRAZIL VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 136 MEXICO VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 137 ARGENTINA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 138 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH

EXHIBIT 139 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES

EXHIBIT 140 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 141 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028

EXHIBIT 142 TURKEY VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 143 SAUDI ARABIA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 144 SOUTH AFRICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 145 UAE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 146 A&D COMPANY ANNUAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 147 GE COMPANY & GE HEALTHCARE ANNUAL REVENUE 2019–2022 ($)

EXHIBIT 148 BAXTER ANNUAL REVENUE 2019–2022 ($ MILLION)

EXHIBIT 149 ICU MEDICAL ANNUAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 150 ICU MEDICAL REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)

EXHIBIT 151 KONINKLIJKE PHILIPS ANNUAL REVENUE 2020-2022 ($ BILLION)

EXHIBIT 152 KONINKLIJKE PHILIPS ANNUAL REVENUE BY BUSINESS SEGMENT 2022 (%)

EXHIBIT 153 MASIMO ANNUAL REVENUE 2019–2022 ($ MILLION)

EXHIBIT 154 MEDTRONIC ANNUAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 155 MEDTRONIC ANNUAL REVENUE SHARE BY BUSINESS SEGMENT 2022 (%)

EXHIBIT 156 MEDTRONIC ANNUAL REVENUE BY GEOGRAPHY 2022 (%)

EXHIBIT 157 NIHON KOHDEN ANNUAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 158 OSI SYSTEMS HEALTHCARE ANNUAL REVENUE 2020–2022 ($ MILLION)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2022

TABLE 3 EXAMPLES OF VITAL SIGN MONITORING DEVICES FOR AMBULATORY CARE SETTINGS

TABLE 4 MAJOR CHALLENGES IN REMOTELY MONITORING PATIENTS WITH VITAL SIGN MONITORING DEVICES

TABLE 5 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)

TABLE 6 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 (%)

TABLE 7 GLOBAL PREVALENCE OF MAJOR CVD CONDITIONS 2022

TABLE 8 VENDORS ACTIVITIES IN BLOOD PRESSURE MONITORING SECTOR

TABLE 9 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)

TABLE 10 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 (%)

TABLE 11 GLOBAL GERIATRIC VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP 2022–2028 ($ BILLION) (GEOGRAPHY)

TABLE 12 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP 2022–2028 (%) (GEOGRAPHY)

TABLE 13 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 14 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP 2022–2028 (%)

TABLE 15 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 16 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP 2022–2028 (%)

TABLE 17 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE 2022–2028 ($ BILLION) (GEOGRAPHY)

TABLE 18 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE 2022–2028 (%) (GEOGRAPHY)

TABLE 19 GLOBAL INFECTIOUS DISEASES REGISTERED CASES 2019–2022

TABLE 20 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE 2022–2028 ($ BILLION) (GEOGRAPHY)

TABLE 21 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE 2022–2028 (%) (GEOGRAPHY)

TABLE 22 NUMBER OF HOSPITALS ICU BEDS PER 100,000 AND TOTAL NUMBER OF HOSPITALS BY COUNTRY

TABLE 23 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS 2022–2028 ($ BILLION) (GEOGRAPHY)

TABLE 24 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS  2022–2028 (%) (GEOGRAPHY)

TABLE 25 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS 2022–2028 ($ BILLION) (GEOGRAPHY)

TABLE 26 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS 2022–2028 (%) (GEOGRAPHY)

TABLE 27 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS 2022–2028 ($ BILLION) (GEOGRAPHY)

TABLE 28 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS 2022–2028 (%) (GEOGRAPHY)

TABLE 29 NUMBER OF MEDICAL ACADEMIC INSTITUTIONS BY COUNTRIES (2022)

TABLE 30 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS 2022−2028 ($ BILLION) (GEOGRAPHY)

TABLE 31 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS 2022−2028 (%) (GEOGRAPHY)

TABLE 32 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 33 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 34 NORTH AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 35 NORTH AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)

TABLE 36 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 37 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)

TABLE 38 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 39 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 40 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 41 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)

TABLE 42 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCTS 2022–2028 ($ BILLION)

TABLE 43 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 44 EUROPE STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 45 EUROPE STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)

TABLE 46 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 47 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)

TABLE 48 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 49 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 50 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 51 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)

TABLE 52 ADVANCES IN REMOTE HEALTHCARE DURING & POST COVID-19 IN APAC

TABLE 53 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCTS 2022–2028 ($ BILLION)

TABLE 54 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 55 APAC STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 56 APAC STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)

TABLE 57 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 58 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)

TABLE 59 APAC VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 60 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 61 APAC VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 62 APAC VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)

TABLE 63 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 64 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 65 LATIN AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 66 LATIN AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)

TABLE 67 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 68 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)

TABLE 69 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 70 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 71 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 72 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)

TABLE 73 MIDDLE EAST & AFRICAN COUNTRIES WITH INCLUSIVE DIGITAL HEALTH INITIATIVES 2022

TABLE 74 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCTS 2022–2028 ($ BILLION)

TABLE 75 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 76 MIDDLE EAST & AFRICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 77 MIDDLE EAST & AFRICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)

TABLE 78 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 79 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)

TABLE 80 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 81 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 82 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 83 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)

TABLE 84 MERGER & ACQUISITIONS IN VITAL SIGNS MONITORING DEVICES MARKET IN RECENT YEARS

TABLE 85 PRODUCT LAUNCHES 2020–2021

TABLE 86 A&D COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 87 CONTEC MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 88 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 89 BAXTER: MAJOR PRODUCT OFFERINGS

TABLE 90 ICU MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 91 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS

TABLE 92 MASIMO: MAJOR PRODUCT OFFERINGS

TABLE 93 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 94 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS

TABLE 95 NONIN: MAJOR PRODUCT OFFERINGS

TABLE 96 OMRON: MAJOR PRODUCT OFFERINGS

TABLE 97 OSI SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 98 100PLUS: MAJOR PRODUCT OFFERINGS

TABLE 99 ARJO (HUNTLEIGH HEALTHCARE LIMITED): MAJOR PRODUCT OFFERINGS

TABLE 100 AMERICAN DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 101 ADVANCED INSTRUMENTATIONS: MAJOR PRODUCT OFFERINGS

TABLE 102 BIOFOURMIS: MAJOR PRODUCT OFFERINGS

TABLE 103 BITTIUM: MAJOR PRODUCT OFFERINGS

TABLE 104 BIOINTELLISENSE: MAJOR PRODUCT OFFERINGS

TABLE 105 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 106 COMPASS HEALTH BRANDS: MAJOR PRODUCT OFFERINGS

TABLE 107 DRÄGERWERK AG & CO.: MAJOR PRODUCT OFFERINGS

TABLE 108 ESSENCE: MAJOR PRODUCT OFFERINGS

TABLE 109 EDAN INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 110 FUKUDA DENSHI: MAJOR PRODUCT OFFERINGS

TABLE 111 HALMA: MAJOR PRODUCT OFFERINGS

TABLE 112 INFINIUM MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 113 MENNEN MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 114 MICROLIFE: MAJOR PRODUCT OFFERINGS

TABLE 115 NURECA: MAJOR PRODUCT OFFERINGS

TABLE 116 OXITONE: MAJOR PRODUCT OFFERINGS

TABLE 117 QARDIO: MAJOR PRODUCT OFFERINGS

TABLE 118 ROSSMAX INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 119 SOLARIS MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 120 SUNSET HEALTHCARE SOLUTIONS: MAJOR PRODUCT OFFERINGS

TABLE 121 TURTLE SHELL TECHNOLOGIES PVT. LTD.: MAJOR PRODUCT OFFERINGS

TABLE 122 VIATOM TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 123 VITALCONNECT: MAJOR PRODUCT OFFERINGS

TABLE 124 VIVALNK: MAJOR PRODUCT OFFERINGS

TABLE 125 VYAIRE MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 126 COSINUSS: MAJOR PRODUCT OFFERINGS

TABLE 127 BETTER LIFE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 128 TAIDOC: MAJOR PRODUCT OFFERINGS

TABLE 129 AXCENT MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 130 GENERAL MEDITECH: MAJOR PRODUCT OFFERINGS

TABLE 131 CLARITY MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 132 HICKS THERMOMETERS INDIA: MAJOR PRODUCT OFFERINGS

TABLE 133 MEDICAL ECONET: MAJOR PRODUCT OFFERINGS

TABLE 134 MEDITECH: MAJOR PRODUCT OFFERINGS

TABLE 135 TABLE 72 SHENZHEN CREATIVE INDUSTRY: MAJOR PRODUCT OFFERINGS

TABLE 136 PROGETTI: MAJOR PRODUCT OFFERINGS

TABLE 137 GETEMED MEDICAL AND INFORMATION TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 138 SHENZHEN UNICARE ELECTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 139 OPTO CIRCUITS (INDIA): MAJOR PRODUCT OFFERINGS

TABLE 140 BEIJING CHOICE ELECTRONIC TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 141 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: MAJOR PRODUCT OFFERINGS

TABLE 142 REMOTE DIAGNOSTIC TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 143 SAMTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 144 CHARMCARE: MAJOR PRODUCT OFFERINGS

TABLE 145 AVI HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 146 RECORDERS & MEDICARE SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 147 ACARE TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 148 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)

TABLE 149 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 (%)

TABLE 150 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 151 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 152 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 153 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)

TABLE 154 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)

TABLE 155 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)

TABLE 156 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 157 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 (%)

TABLE 158 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)

TABLE 159 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY PATIENT GROUP

4.3.3 MARKET SEGMENTATION BY APPLICATION

4.3.4 MARKET SEGMENTATION BY END USER

4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 PREMIUM INSIGHTS

6.1 OVERVIEW

6.1.1 MARKET SEGMENTATION

 

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

 

9 MARKET OPPORTUNITIES & TRENDS

9.1 TECHNOLOGICAL ADVANCES IN VITAL SIGNS MONITORING DEVICES

9.2 SHIFT TOWARD REMOTE PATIENT MONITORING TECHNOLOGIES

9.3 HIGH ADOPTION OF PATIENT-CENTRIC DIGITAL SYSTEMS & TELEMEDICINE

 

10 MARKET GROWTH ENABLERS

10.1 RISE IN BURDEN OF CHRONIC DISORDERS

10.2 AVAILABILITY OF INTEGRATED VITAL SIGNS MONITORING DEVICES

10.3 PARADIGM SHIFT TOWARD OUTPATIENT CARE

10.4 EXPANSION OF PATIENT POPULATIONS & SHORTAGE OF HEALTHCARE WORKERS

 

11 MARKET RESTRAINTS

11.1 CHALLENGES ASSOCIATED WITH REMOTELY MONITORING PATIENTS THROUGH VITAL SIGN MONITORS

11.2 FALSE ALARMS RELATED TO VITAL SIGN MONITORING DEVICES

11.3 CYBERSECURITY & RELATED LIMITATIONS OF VITAL SIGNS MONITORING DEVICES

11.4 PERCEPTIONS OF INADEQUATE ACCURACY & RELIABILITY OF WIRELESS VITAL SIGNS MONITORING DEVICES

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.1.1 PRODUCT INSIGHTS: MARKET ANALYSIS

12.1.2 STANDALONE VITAL SIGN MONITORING DEVICES TYPES INSIGHTS: MARKET ANALYSIS

12.1.3 PATIENT GROUP INSIGHTS: MARKET ANALYSIS

12.1.4 APPLICATION INSIGHTS: MARKET ANALYSIS

12.1.5 END-USER INSIGHTS: MARKET ANALYSIS

12.1.6 GEOGRAPHY INSIGHTS: MARKET ANALYSIS

12.2 MARKET SIZE & FORECAST

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 STANDALONE VITAL SIGN MONITORS

13.3.1 MARKET OVERVIEW

13.3.2 MARKET BY GEOGRAPHY

13.3.3 HEART RATE/ CARDIAC MONITORS: MARKET SIZE & FORECAST

13.3.4 PULSE OXIMETERS: MARKET SIZE & FORECAST

13.3.5 BLOOD PRESSURE MONITORS: MARKET SIZE & FORECAST

13.3.6 BODY TEMPERATURE MONITORS: MARKET SIZE & FORECAST

13.4 INTEGRATED VITAL SIGN MONITORS

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

 

14 PATIENT GROUP

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 GERIATRIC

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 PEDIATRIC

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 ADULTS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

 

15 APPLICATION

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 CHRONIC CARE

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 ACUTE CARE

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

 

16 END USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 HOSPITALS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 OUTPATIENT CARE SETTINGS

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

16.5 HOMECARE SETTINGS & INDIVIDUALS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.5.3 MARKET BY GEOGRAPHY

16.6 OTHERS

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.6.3 MARKET BY GEOGRAPHY

 

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

 

18 NORTH AMERICA

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 PRODUCT

18.3.1 MARKET SIZE & FORECAST

18.4 STANDALONE VITAL SIGN MONITORS

18.4.1 MARKET SIZE & FORECAST

18.5 PATIENT GROUP

18.5.1 MARKET SIZE & FORECAST

18.6 APPLICATION

18.6.1 MARKET SIZE & FORECAST

18.7 END USER

18.7.1 MARKET SIZE & FORECAST

18.8 KEY COUNTRIES

18.8.1 US: MARKET SIZE & FORECAST

18.8.2 CANADA: MARKET SIZE & FORECAST

 

19 EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 PRODUCT

19.3.1 MARKET SIZE & FORECAST

19.4 STANDALONE VITAL SIGN MONITORS

19.4.1 MARKET SIZE & FORECAST

19.5 PATIENT GROUP

19.5.1 MARKET SIZE & FORECAST

19.6 APPLICATION

19.6.1 MARKET SIZE & FORECAST

19.7 END USER

19.7.1 MARKET SIZE & FORECAST

19.8 KEY COUNTRIES

19.8.1 GERMANY: MARKET SIZE & FORECAST

19.8.2 FRANCE: : MARKET SIZE & FORECAST

19.8.3 UK: MARKET SIZE & FORECAST

19.8.4 ITALY: MARKET SIZE & FORECAST

19.8.5 SPAIN: MARKET SIZE & FORECAST

 

20 APAC

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 PRODUCT

20.3.1 MARKET SIZE & FORECAST

20.4 STANDALONE VITAL SIGN MONITORS

20.4.1 MARKET SIZE & FORECAST

20.5 PATIENT GROUP

20.5.1 MARKET SIZE & FORECAST

20.6 APPLICATION

20.6.1 MARKET SIZE & FORECAST

20.7 END USER

20.7.1 MARKET SIZE & FORECAST

20.8 KEY COUNTRIES

20.8.1 CHINA: MARKET SIZE & FORECAST

20.8.2 JAPAN: MARKET SIZE & FORECAST

20.8.3 INDIA: MARKET SIZE & FORECAST

20.8.4 SOUTH KOREA: MARKET SIZE & FORECAST

20.8.5 AUSTRALIA: MARKET SIZE & FORECAST

 

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 PRODUCT

21.3.1 MARKET SIZE & FORECAST

21.4 STANDALONE VITAL SIGN MONITORS

21.4.1 MARKET SIZE & FORECAST

21.5 PATIENT GROUP

21.5.1 MARKET SIZE & FORECAST

21.6 APPLICATION

21.6.1 MARKET SIZE & FORECAST

21.7 END USER

21.7.1 MARKET SIZE & FORECAST

21.8 KEY COUNTRIES

21.8.1 BRAZIL: MARKET SIZE & FORECAST

21.8.2 MEXICO: MARKET SIZE & FORECAST

21.8.3 ARGENTINA: MARKET SIZE & FORECAST

 

22 MIDDLE EAST & AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.3 PRODUCT

22.3.1 MARKET SIZE & FORECAST

22.4 STANDALONE VITAL SIGN MONITORS

22.4.1 MARKET SIZE & FORECAST

22.5 PATIENT GROUP

22.5.1 MARKET SIZE & FORECAST

22.6 APPLICATION

22.6.1 MARKET SIZE & FORECAST

22.7 END USER

22.7.1 MARKET SIZE & FORECAST

22.8 KEY COUNTRIES

22.8.1 TURKEY: MARKET SIZE & FORECAST

22.8.2 SAUDI ARABIA: MARKET SIZE & FORECAST

22.8.3 SOUTH AFRICA: MARKET SIZE & FORECAST

22.8.4 UAE: MARKET SIZE & FORECAST

 

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.1.1 MAJOR MERGERS & ACQUISITIONS

23.1.2 PRODUCTS LAUNCHES

 

24 KEY COMPANY PROFILES

24.1 A&D COMPANY

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.1.3 KEY STRATEGIES

24.1.4 KEY STRENGTHS

24.1.5 KEY OPPORTUNITIES

24.2 CONTEC MEDICAL SYSTEMS

24.2.1 BUSINESS OVERVIEW

24.2.2 PRODUCT OFFERINGS

24.2.3 KEY STRATEGIES

24.2.4 KEY STRENGTHS

24.2.5 KEY OPPORTUNITIES

24.3 GE HEALTHCARE

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERINGS

24.3.3 KEY STRATEGIES

24.3.4 KEY STRENGTHS

24.3.5 KEY OPPORTUNITIES

24.4 BAXTER

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.4.3 KEY STRATEGIES

24.4.4 KEY STRENGTHS

24.4.5 KEY OPPORTUNITIES

24.5 ICU MEDICAL

24.5.1 BUSINESS OVERVIEW

24.5.2 PRODUCT OFFERINGS

24.5.3 KEY STRATEGIES

24.5.4 KEY STRENGTHS

24.5.5 KEY OPPORTUNITIES

24.6 KONINKLIJKE PHILIPS

24.6.1 BUSINESS OVERVIEW

24.6.2 PRODUCT OFFERINGS

24.6.3 KEY STRATEGIES

24.6.4 KEY STRENGTHS

24.6.5 KEY OPPORTUNITIES

24.7 MASIMO

24.7.1 BUSINESS OVERVIEW

24.7.2 PRODUCT OFFERINGS

24.7.3 KEY STRATEGIES

24.7.4 KEY STRENGTHS

24.7.5 KEY OPPORTUNITIES

24.8 MEDTRONIC

24.8.1 BUSINESS OVERVIEW

24.8.2 PRODUCT OFFERINGS

24.8.3 KEY STRATEGIES

24.8.4 KEY STRENGTHS

24.8.5 KEY OPPORTUNITIES

24.9 NIHON KOHDEN

24.9.1 BUSINESS OVERVIEW

24.9.2 PRODUCT OFFERINGS

24.9.3 KEY STRATEGIES

24.9.4 KEY STRENGTHS

24.9.5 KEY OPPORTUNITIES

24.10 NONIN

24.10.1 BUSINESS OVERVIEW

24.10.2 PRODUCT OFFERINGS

24.10.3 KEY STRATEGIES

24.10.4 KEY STRENGTHS

24.10.5 KEY OPPORTUNITIES

24.11 OMRON

24.11.1 BUSINESS OVERVIEW

24.11.2 PRODUCT OFFERINGS

24.11.3 KEY STRATEGIES

24.11.4 KEY STRENGTHS

24.11.5 KEY OPPORTUNITIES

24.12 OSI SYSTEMS

24.12.1 BUSINESS OVERVIEW

24.12.2 PRODUCT OFFERINGS

24.12.3 KEY STRATEGIES

24.12.4 KEY STRENGTHS

24.12.5 KEY OPPORTUNITIES

 

25 OTHER PROMINENT VENDORS

25.1 100PLUS

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT OFFERINGS

25.2 ARJO (HUNTLEIGH HEALTHCARE LIMITED)

25.2.1 BUSINESS OVERVIEW

25.2.2 PRODUCT OFFERINGS

25.3 AMERICAN DIAGNOSTICS

25.3.1 BUSINESS OVERVIEW

25.3.2 PRODUCT OFFERINGS

25.4 ADVANCED INSTRUMENTATIONS

25.4.1 BUSINESS OVERVIEW

25.4.2 PRODUCT OFFERINGS

25.5 BIOFOURMIS

25.5.1 BUSINESS OVERVIEW

25.5.2 PRODUCT OFFERINGS

25.6 BITTIUM

25.6.1 BUSINESS OVERVIEW

25.6.2 PRODUCT OFFERINGS

25.7 BIOINTELLISENSE

25.7.1 BUSINESS OVERVIEW

25.7.2 PRODUCT OFFERINGS

25.8 CARDINAL HEALTH

25.8.1 BUSINESS OVERVIEW

25.8.2 PRODUCT OFFERINGS

25.9 COMPASS HEALTH BRANDS

25.9.1 BUSINESS OVERVIEW

25.9.2 PRODUCT OFFERINGS

25.10 DRÄGERWERK AG & CO.

25.10.1 BUSINESS OVERVIEW

25.10.2 PRODUCT OFFERINGS

25.11 ESSENCE

25.11.1 BUSINESS OVERVIEW

25.11.2 PRODUCT OFFERINGS

25.12 EDAN INSTRUMENTS

25.12.1 BUSINESS OVERVIEW

25.12.2 PRODUCT OFFERINGS

25.13 FUKUDA DENSHI

25.13.1 BUSINESS OVERVIEW

25.13.2 PRODUCT OFFERINGS

25.14 HALMA

25.14.1 BUSINESS OVERVIEW

25.14.2 PRODUCT OFFERINGS

25.15 INFINIUM MEDICAL

25.15.1 BUSINESS OVERVIEW

25.15.2 PRODUCT OFFERINGS

25.16 MENNEN MEDICAL

25.16.1 BUSINESS OVERVIEW

25.16.2 PRODUCT OFFERINGS

25.17 MICROLIFE

25.17.1 BUSINESS OVERVIEW

25.17.2 PRODUCT OFFERINGS

25.18 NURECA

25.18.1 BUSINESS OVERVIEW

25.18.2 PRODUCT OFFERINGS

25.19 OXITONE

25.19.1 BUSINESS OVERVIEW

25.19.2 PRODUCT OFFERINGS

25.20 QARDIO

25.20.1 BUSINESS OVERVIEW

25.20.2 PRODUCT OFFERINGS

25.21 ROSSMAX INTERNATIONAL

25.21.1 BUSINESS OVERVIEW

25.21.2 PRODUCT OFFERINGS

25.22 SOLARIS MEDICAL TECHNOLOGY

25.22.1 BUSINESS OVERVIEW

25.22.2 PRODUCT OFFERINGS

25.23 SUNSET HEALTHCARE SOLUTIONS

25.23.1 BUSINESS OVERVIEW

25.23.2 PRODUCT OFFERINGS

25.24 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE)

25.24.1 BUSINESS OVERVIEW

25.24.2 PRODUCT OFFERINGS

25.25 VIATOM TECHNOLOGY

25.25.1 BUSINESS OVERVIEW

25.25.2 PRODUCT OFFERINGS

25.26 VITALCONNECT

25.26.1 BUSINESS OVERVIEW

25.26.2 PRODUCT OFFERINGS

25.27 VIVALNK

25.27.1 BUSINESS OVERVIEW

25.27.2 PRODUCT OFFERINGS

25.28 VYAIRE MEDICAL

25.28.1 BUSINESS OVERVIEW

25.28.2 PRODUCT OFFERINGS

25.29 COSINUSS

25.29.1 BUSINESS OVERVIEW

25.29.2 PRODUCT OFFERINGS

25.30 BETTER LIFE MEDICAL TECHNOLOGY

25.30.1 BUSINESS OVERVIEW

25.30.2 PRODUCT OFFERINGS

25.31 TAIDOC

25.31.1 BUSINESS OVERVIEW

25.31.2 PRODUCT OFFERINGS

25.32 AXCENT MEDICAL

25.32.1 BUSINESS OVERVIEW

25.32.2 PRODUCT OFFERINGS

25.33 GENERAL MEDITECH

25.33.1 BUSINESS OVERVIEW

25.33.2 PRODUCT OFFERINGS

25.34 CLARITY MEDICAL

25.34.1 BUSINESS OVERVIEW

25.34.2 PRODUCT OFFERINGS

25.35 HICKS THERMOMETERS INDIA

25.35.1 BUSINESS OVERVIEW

25.35.2 PRODUCT OFFERINGS

25.36 MEDICAL ECONET

25.36.1 BUSINESS OVERVIEW

25.36.2 PRODUCT OFFERINGS

25.37 MEDITECH

25.37.1 BUSINESS OVERVIEW

25.37.2 PRODUCT OFFERINGS

25.38 SHENZHEN CREATIVE INDUSTRY

25.38.1 BUSINESS OVERVIEW

25.38.2 PRODUCT OFFERINGS

25.39 PROGETTI

25.39.1 BUSINESS OVERVIEW

25.39.2 PRODUCT OFFERINGS

25.40 GENTEMED MEDICAL AND INFROMATION TECHNOLOGY

25.40.1 BUSINESS OVERVIEW

25.40.2 PRODUCT OFFERINGS

25.41 SHENZHEN UNICARE ELECTRONIC

25.41.1 BUSINESS OVERVIEW

25.41.2 PRODUCT OFFERINGS

25.42 OPTO CIRCUITS (INDIA)

25.42.1 BUSINESS OVERVIEW

25.42.2 PRODUCT OFFERINGS

25.43 BEIJING CHOICE ELECTRONIC TECHNOLOGY

25.43.1 BUSINESS OVERVIEW

25.43.2 PRODUCT OFFERINGS

25.44 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS

25.44.1 BUSINESS OVERVIEW

25.44.2 PRODUCT OFFERINGS

25.45 REMOTE DIAGNOSTIC TECHNOLOGIES

25.45.1 BUSINESS OVERVIEW

25.45.2 PRODUCT OFFERINGS

25.46 ZZZSAMTRONIC

25.46.1 BUSINESS OVERVIEW

25.46.2 PRODUCT OFFERINGS

25.47 CHARMCARE

25.47.1 BUSINESS OVERVIEW

25.47.2 PRODUCT OFFERINGS

25.48 AVI HEALTHCARE

25.48.1 BUSINESS OVERVIEW

25.48.2 PRODUCT OFFERINGS

25.49 RECORDERS & MEDICARE SYSTEMS

25.49.1 BUSINESS OVERVIEW

25.49.2 PRODUCT OFFERINGS

25.50 ACARE TECHNOLOGY

25.50.1 BUSINESS OVERVIEW

25.50.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

 

27 QUANTITATIVE SUMMARY

27.1 MARKET BY GEOGRAPHY

27.2 MARKET BY PRODUCT

27.3 MARKET BY STANDALONE VITAL SIGN MONITORS

27.4 MARKET BY PATIENT GROUP

27.5 MARKET BY APPLICATION

27.6 MARKET BY END USER

 

28 APPENDIX

28.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the global vital signs monitoring devices market?

The global vital signs monitoring devices market size was valued at USD 20.60 billion in 2022 and is expected to reach USD 33.36 billion by 2028.

What is the growth rate of the vital signs monitoring devices market?

The global vital signs monitoring devices market is growing at a CAGR of 8.36% from 2022-2028.

What are the rising trends in the vital signs monitoring devices industry?

The rising trends in the vital signs monitoring devices industry are technology development in vital sign monitoring devices, a growing shift towards remote patient monitoring technology, and enhanced adoption of patient-centric digital systems with wearable devices & telemedicine.

Which region holds the most significant global vital signs monitoring devices market share?

North America dominated the global vital signs monitoring devices market share in 2022, accounting for over 35%.

Who are the key players in the global vital signs monitoring devices market?

A&D Company, Contec Medical Systems, GE Healthcare, Baxter, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems are the key players in the vital global vital signs monitoring devices market.